Korea’s pharmaceutical technology transfer fees top 2.5 trillion won in 22 years

The country saw a drug-related cumulative technology transfer fee of 2.5 trillion won ($2.3 billion) over the past 22 years since Hanmi Pharma exported its formulation technology of ceftriaxone to Switzerland based Roche in 1989, the Korea Drug Research Association said Wednesday.

The association said that its 32 member companies has owned a total of 159 new chemical compounds as of November...